Patents Assigned to 64-X, Inc.
  • Mammalian cells and methods for engineering the same
    Patent number: 12241062
    Abstract: The present disclosure provides mammalian cell lines for expression of viral vectors, and methods of making and using the same. Provided methods employ use of identifiers that are capable of being packaged into a viral vector to select and/or identify mammalian cell lines with engineered sequences associated with beneficial characteristics for viral vectors production. Exemplary viral vectors include AAV vectors.
    Type: Grant
    Filed: October 23, 2023
    Date of Patent: March 4, 2025
    Assignee: 64-X, Inc.
    Inventors: Alexis Rovner, Gaurab Chakrabarti, David Thompson, Gregory Sieczkiewicz